Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
23.20
-0.38 (-1.61%)
Jul 3, 2025, 1:00 PM - Market closed
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $1.09 billion as of July 3, 2025. Its market cap has decreased by -44.84% in one year.
Market Cap
1.09B
Enterprise Value
1.51B
1-Year Change
-44.84%
Ranking
Category
Stock Price
$23.20
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $1.09B, an increase of 192.26%. That is a compound annual growth rate of 10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.09B | -38.74% |
| Dec 31, 2024 | 1.79B | -39.75% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |